FDA Sends Back Filing For Pfizer's Tafamidis, Acquired in FoldRx Deal

Two months after Pfizer files an NDA for the orphan drug, the agency issues a Refusal To File Letter requesting more information.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet